Historial de carrera de Safi R. Bahcall
Antiguos cargos conocidos de Safi R. Bahcall.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Director/Miembro de la Junta | 05/10/2010 | 03/03/2014 |
| Director Ejecutivo | 01/07/2001 | 03/03/2014 | |
| Fundador | 24/07/2009 | 03/03/2014 | |
| Presidente | 01/07/2001 | 03/03/2014 |
Formación de Safi R. Bahcall.
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Safi R. Bahcall
- Experiencia
